Clinical note: allergic reaction to daunomycin (NSC-82151).
D000293:Adolescent; D000799:Angioedema / Q000139:chemically induced; D003630:Daunorubicin / Q000009:adverse effects*; D004342:Drug Hypersensitivity; D005260:Female; D006801:Humans; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D012075:Remission, Spontaneous; D014581:Urticaria / Q000139:chemically induced; D014750:Vincristine / Q000627:therapeutic use
D014750:Vincristine; D015122:Mercaptopurine; D011241:Prednisone; D008727:Methotrexate; D003630:Daunorubicin